DGXQUEST DIAGNOSTICS INC

NYSE questdiagnostics.com


$ 146.79 $ 1.10 (0.75 %)    

Tuesday, 06-Aug-2024 15:59:57 EDT
QQQ $ 437.58 $ 4.16 (0.96 %)
DIA $ 389.72 $ 3.15 (0.81 %)
SPY $ 522.63 $ 4.77 (0.92 %)
TLT $ 96.88 $ -2.21 (-2.24 %)
GLD $ 220.73 $ -1.78 (-0.8 %)
$ 146.89
$ 146.67 x 100
$ 146.80 x 100
-- - --
$ 116.97 - $ 151.78
822,562
na
16.35B
$ 0.77
$ 19.47
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-24-2024 06-30-2024 10-Q
2 04-24-2024 03-31-2024 10-Q
3 02-22-2024 12-31-2023 10-K
4 10-25-2023 09-30-2023 10-Q
5 07-27-2023 06-30-2023 10-Q
6 04-28-2023 03-31-2023 10-Q
7 02-21-2023 12-31-2022 10-K
8 10-21-2022 09-30-2022 10-Q
9 07-22-2022 06-30-2022 10-Q
10 04-22-2022 03-31-2022 10-Q
11 02-28-2022 12-31-2021 10-K
12 10-22-2021 09-30-2021 10-Q
13 07-23-2021 06-30-2021 10-Q
14 04-23-2021 03-31-2021 10-Q
15 02-22-2021 12-31-2020 10-K
16 10-23-2020 09-30-2020 10-Q
17 07-24-2020 06-30-2020 10-Q
18 05-04-2020 03-31-2020 10-Q
19 02-20-2020 12-31-2019 10-K
20 10-23-2019 09-30-2019 10-Q
21 07-24-2019 06-30-2019 10-Q
22 04-24-2019 03-31-2019 10-Q
23 02-21-2019 12-31-2018 10-K
24 10-24-2018 09-30-2018 10-Q
25 07-25-2018 06-30-2018 10-Q
26 04-20-2018 03-31-2018 10-Q
27 02-23-2018 12-31-2017 10-K
28 10-19-2017 09-30-2017 10-Q
29 07-25-2017 06-30-2017 10-Q
30 04-21-2017 03-31-2017 10-Q
31 02-22-2017 12-31-2016 10-K
32 10-21-2016 09-30-2016 10-Q
33 07-25-2016 06-30-2016 10-Q
34 04-27-2016 03-31-2016 10-Q
35 02-26-2016 12-31-2015 10-K
36 10-29-2015 09-30-2015 10-Q
37 07-30-2015 06-30-2015 10-Q
38 04-30-2015 03-31-2015 10-Q
39 02-24-2015 12-31-2014 10-K
40 10-30-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 labcorps-stock-soars-after-q2-performance-analyst-highlights-strong-position-in-healthcare-sector

LabCorp reported Q2 2024 adjusted EPS of $3.94, surpassing expectations of $3.78. Sales increased by 6.2% to $3.22 billion, dri...

 piper-sandler-maintains-neutral-on-quest-diagnostics-raises-price-target-to-150

Piper Sandler analyst David Westenberg maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target fro...

Core News & Articles

The joint offerings will range from exploratory panel development to the manufacturing and distribution of FDA-approved diagnos...

 baird-maintains-neutral-on-quest-diagnostics-raises-price-target-to-154

Baird analyst Eric Coldwell maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $153 to $...

 quest-diagnostics-q2-earnings-performance-suggests-stable-stock-modest-growth-ahead-analyst-says

Quest Diagnostics reported a second-quarter adjusted EPS of $2.35, surpassing the consensus of $2.34. Sales rose 2.5% year-over...

 small-cap-gains-resume-ahead-of-major-tech-earnings-ups-faces-worst-day-ever-bitcoin-dips-below-66000-whats-driving-markets-tuesday

Tuesday's Wall Street session was mixed, with small-caps outperforming large-caps as investors awaited earnings from Alphab...

 us-stock-futures-little-changed-as-traders-brace-for-q2-reports-from-alphabet-tesla-there-remains-strong-fundamental-support-for-large-caps-says-economist

The market mood turned jittery after Monday’s rebound, with index futures trading on either side of the unchanged line early Tu...

 tesla-alphabet-gm-ford-lead-earnings-parade-this-week-as-market-struggles-to-sustain-the-summer-rally

The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season.

 quest-diagnostics-says-patient-services--customer-contact-teams-operating-with-reduced-capacity-so-customers-may-experience-longer-wait--service-times

- Reuters

 quest-diagnostics-says-taking-swift-action-to-respond-recover-and-restore-operations-due-to-global-information-outage-that-occurred-this-morning

- Reuters

 truist-securities-maintains-hold-on-quest-diagnostics-raises-price-target-to-158

Truist Securities analyst David Macdonald maintains Quest Diagnostics (NYSE:DGX) with a Hold and raises the price target fro...

 quest-diagnostics-to-acquire-outreach-laboratory-services-of-ohiohealth-financial-details-of-the-transaction-were-not-disclosed

Goal to broaden access to cost-effective and innovative laboratory services in OhioSECAUCUS, N.J. and COLUMBUS, Ohio, July 10, ...

 citigroup-upgrades-quest-diagnostics-to-buy-raises-price-target-to-165

Citigroup analyst Patrick Donnelly upgrades Quest Diagnostics (NYSE:DGX) from Neutral to Buy and raises the price target fro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION